← Leaderboards
Charles Lee Evavold
Harvard Medical School
$519,662
Attributed
$519,662
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $453.8K · FY2019–25$500K$375K$250K$125K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$519,662 · 2
By mechanism
R35$453,750 · 1
F31$65,912 · 1
Top collaborators
No co-investigators on record.
Most similar at Harvard Medical School
Same institution · by research overlap
- Hao Wu$47,906,316
- Arlene H Sharpe$68,359,602
- Michaela Ulrike Gack$22,395,027
- Christophe O Benoist$53,813,482
- David Z Rudner$19,646,254
Others in their field
Other Emerging Leaders on “Prevent”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Leonard Freedman · Leidos Biomedical Research, Inc.$141,293,697
- Kimberly Smith · Ppd Development Lp$115,671,664
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$112,282,390
- Beth Baseler · Leidos Biomedical Research, Inc.$100,071,064
- Peter W Pisters · University Of Tx Md Anderson Can Ctr$76,895,673
Research focus
PreventCellsMembranePathway InteractionsProgramsCell SurvivalInfectionMediatingNonlyticPathogen DetectionSignal TransductionVaccinationCell DeathCessation Of LifeImmune ActivationImmune ResponseInflammationLyticCytolysisCell Death ProcessBehaviorCaspaseCasp1 GeneBase